Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: HGUE-C-1 is an atypical and novel colon carcinoma cell line

Figure 4

Effects of 5-FU (4A) and irinotecan (4B) on HGUE-C 1, HT-29, HCT-116 and SW620 cell proliferation. Sensitivity to both antineoplasic agents was also determined in HGUE-C-1, HT-29, HCT-116 and SW620 cells by MTT assays. Cells were grown in 96-well plates, treated with different concentration of drugs for 72 hours and incubated with MTT. Proliferation rates were determined by colourimetry and the average of at least four experiments is represented and referred as percentage of control. Error bars are the S.E.M. *p < 0.05, **p < 0.01 versus HT-29 values.

Back to article page